NUMI — Numinus Wellness Share Price
- CA$11.22m
- CA$14.60m
- CA$23.18m
- 19
- 41
- 17
- 15
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.42 | ||
Price to Tang. Book | 2.42 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.56 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -186.7% | ||
Return on Equity | -143.15% | ||
Operating Margin | -84.8% |
Financial Summary
Year End 31st Aug | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | n/a | 0.88 | 1.51 | 6.49 | 23.18 | 19.93 | 24.09 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.
Directors
- Payton Nyquvest PRE
- John Fong CFO
- Michael Tan COO
- Devon Christie OTH
- Judy Varga OTH
- Stacey Wallin OTH
- Evan Wood OTH
- Edwin Garner IND
- Allen Morishita IND
- Larry Timlick IND (63)
- Last Annual
- August 31st, 2023
- Last Interim
- May 31st, 2024
- Incorporated
- June 26th, 1962
- Public Since
- August 10th, 1982
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 320,551,600
- Address
- 393 Laurier Ave W, MONTREAL, H2V 2K3
- Web
- https://numinus.com/
- Phone
- +1 6043292079
- Auditors
- Davidson & Company LLP
Upcoming Events for NUMI
Q1 2025 Numinus Wellness Inc Earnings Release
Similar to NUMI
Appili Therapeutics
Toronto Stock Exchange
Avicanna
Toronto Stock Exchange
Briacell Therapeutics
Toronto Stock Exchange
Cardiol Therapeutics
Toronto Stock Exchange
COSCIENS Biopharma
Toronto Stock Exchange
FAQ
As of Today at 22:23 UTC, shares in Numinus Wellness are trading at CA$0.04. This share price information is delayed by 15 minutes.
Shares in Numinus Wellness last closed at CA$0.04 and the price had moved by -82.05% over the past 365 days. In terms of relative price strength the Numinus Wellness share price has underperformed the Toronto Stock Exchange 300 Composite Index by -84.18% over the past year.
The overall consensus recommendation for Numinus Wellness is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreNuminus Wellness does not currently pay a dividend.
Numinus Wellness does not currently pay a dividend.
Numinus Wellness does not currently pay a dividend.
To buy shares in Numinus Wellness you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.04, shares in Numinus Wellness had a market capitalisation of CA$11.22m.
Here are the trading details for Numinus Wellness:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: NUMI
Based on an overall assessment of its quality, value and momentum Numinus Wellness is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Numinus Wellness is CA$1.10. That is 3042.86% above the last closing price of CA$0.04.
Analysts covering Numinus Wellness currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Numinus Wellness. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -72.13%.
As of the last closing price of CA$0.04, shares in Numinus Wellness were trading -59.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Numinus Wellness PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Numinus Wellness' management team is headed by:
- Payton Nyquvest - PRE
- John Fong - CFO
- Michael Tan - COO
- Devon Christie - OTH
- Judy Varga - OTH
- Stacey Wallin - OTH
- Evan Wood - OTH
- Edwin Garner - IND
- Allen Morishita - IND
- Larry Timlick - IND